Background: It is known that platelet-derived growth factor (PDGF) receptors are expressed in hair follicle (HF) epithelium.
Introduction
Platelet-derived growth factor (PDGF) is a potent mitogen produced in a variety of cell types including keratinocytes and endothelial cells, and is important for cell growth, proliferation and differentiation [1] . PDGF-AA and Platelet-derived growth factor receptor (PDGFR)-alpha are expressed in human hair follicles during fetal development [2] , and a role for PDGF-AA in hair follicle development has been suggested by the fact that hair formation was perturbed by injection of PDGFR-alpha antibodies into newborn mice [3] . There are several different isoforms of PDGF (PDGF-AA, AB, BB and CC) that exert their biological activities by binding to two distinct cell-surface receptors, which were shown to be ligand-induced tyrosine kinase proteins possessing intrinsic tyrosine kinase activity during differentiation [1] .
The PDGF receptor-alpha (PDGFR-alpha) has been shown to bind to all three PDGF chains (PDGF A, B and C), whereas the PDGF receptor-beta (PDGFR-beta) is specific for the PDGF-B polypeptide. Both types of PDGF receptors are expressed in human follicular keratinocytes, although the mesenchymal dermal papilla cells only express PDGFR-alpha. It is known that the expression levels of PDGF isoforms in vitro can be influenced by treatment with cytokines known to be positive and negative regulators of hair follicle growth activity, including IL-1beta, IL-4, interferon-gamma [4] .
PDGF-A null mice were reported to develop a skin and hair phenotype characterized by progressive loss of dermal mesenchymal cells, thereby causing an impaired formation of dermal papilla components giving rise to 3 the hair follicle [5] . They suggested that the cutaneous phenotype of PDGF-A null mice might also be the result of progressive depletion of multipotent dermal mesenchymal progenitor cells, due to their reduced proliferation caused by an absence of PDGF-A.
From these facts, we hypothesized that PDGFs might be a positive regulator of hair growth in vivo. In this study, we analyzed the effect of cutaneous injections of recombinant human PDGF-AA and PDGF-BB on hair follicle growth in mice. As a result, local injections of PDGF-AA and PDGF-BB have anagen inducible effects on murine hair follicles. We confirmed that the PDGF-AA hair growth effect was blocked by simultaneous injection of anti-PDGF-AA antibody. In addition, we showed hair growth restraint effects after injection with anti-human PDGF-AA antibody and anti-human PDGF-BB antibody into mouse skin during the second anagen phase of HFs. We have clearly demonstrated that local injection of PDGF isoforms can induce and maintain the anagen phase of murine hair follicles, and these effects might be associated with the upregulation of Sonic hedgehog (Shh), Wnt5a and Lef-1. These results suggest the possibility that a local application of PDGF might be a worthwhile treatment for alopecia.
Materials and Methods

Reagents
We used recombinant human PDGF isoforms and antibodies as follows: 
Animals
Mice used in this study were male mice C3H/HeN (47 day old, second telogen phase; body weight, 19-20g) (CLER, Japan) for anagen induction experiments and 28-day-old male C3H/HeN mice (second anagen phase; body weight, 16-17g) for telogen induction experiments.
Anagen induction by PDGF local injection
All the animal experiments were performed under the approval of the ethical committee on animal study in Hokkaido University. Recombinant human PDGF-AA and PDGF-BB were dissolved in sterile and toxin-free phosphate-buffered saline containing 0.1% bovine serum albumin (0.1% BSA-PBS). 1μg PDGF-AA or PDGF-BB dissolved in 100μl of 0.1% BSA-PBS and 0.1%BSA-PBS for controls were intradermally injected into the dorsal skin of 47-day-old male C3H mice (second telogen) once daily for 5 consecutive days (total 5μg of PDGF isoforms) (PDGF-AA, n=5; 5 PDGF-BB, n=5; control, n=5). All mice were sacrificed 10 days after the first injection, and skin samples were prepared for further studies. In order to confirm the effects of different PDGF isoforms, anti-PDGF-AA antibody or anti-PDGF-BB antibody was injected just after each injection of PDGF-AA or PDGF-BB (anti-PDGF-AA antibody following PDGF-AA, n=5; anti-PDGF-BB antibody following PDGF-BB, n=5).
We also dissolved PDGF-AA or PDGF-BB in 1% hyaluronic acid for single injection. 5μg of PDGF-AA or PDGF-BB in 1% hyaluronic acid was injected into the dorsal skin of 47-day-old male C3H mice (second telogen) only once. Only 1% hyaluronic acid was injected as a negative control (PDGF-AA in hyaluronic acid, n=5; PDGF-BB in hyaluronic acid, n=5; control, n=5).
Catagen induction by injections of anti-PDGF antibodies
1μg Anti-human PDGF-AA polyclonal antibody or anti-human PDGF-BB polyclonal antibody dissolved in 100μl of 0.1% BSA-PBS were injected into the dorsal skin of five C3H/HeN male mice (28-days-old, second anagen phase; body weight, 16-17g) once daily for 5 consecutive days (total 5μg of PDGF isoforms), and then sacrificed 10 days after the first injection. Control mice at the same age were injected with 100μl of 0.1% BSA-PBS once daily for 5 consecutive days (anti-PDGF-AA antibody, n=5; anti-PDGF-BB antibody, n=5; control, n=5). 6 
Evaluation of hair growth activity
Hair growth activity of the mouse skin samples was evaluated in H&E sections. The skin sample resected from the injection site was fixed in 10% buffered formalin solution and paraffin embedded. A 5μm thick section was stained with hematoxylin and eosin. Skin thickness was defined as the distance from the epidermal granular layer to the top of the panniculus carnosus and was used as a parameter indicating hair follicle length [6] . Measurements were carried out in three fields per mouse, and their average value was expressed in μm.
The data from the samples were compared with those of the 0.1% BSA-PBS injected control samples, and analyzed by Student's paired T-test. Data with P values less than 0.05 were taken as significant.
It is known that alkaline phosphatase staining appears in anagen phase outer root sheath [7] . For the alkaline phosphatase staining, fresh mouse skin specimens embedded in OCT compound (Tissue-Tek, Sakura, Japan) were quick-frozen using an isopentane cooled bath with dry ice, and sections were cut in the cryostat. The skin samples were stained with alkaline phosphatase and the hair cycle phase was identified from the staining patterns.
Expression of signaling molecules
We studied expression of signaling molecules, Shh, Wnt5a, Lef-1 and Stat3, by immunohistchemical staining in the skin where anagen phase had been induced by PDGF injections, and by using real time-RT-PCR.
For the real time-RT-PCR analysis, pieces of skin tissue (about 60mg/ mouse) were treated with 1.5 ml Trizol (Invitrogen, Karlsruhe, Germany) and were crushed and mixted using a mortar. The RNA was then extracted using a standard protocol. After RNA preparation, the total RNA was treated with DNase I (Invitrogen, Karlsruhe, Germany) 1U/1μg-RNA for 15 minutes at room temperature followed by inactivation with EDTA (Sigma, Munich, Germany). After the DNase treatment, genomic DNA was not detected in the sample by PCR. First-strain cDNA synthesis was performed using Superscript II reverse transcriptase (Gibco, Karlsruhe, Germany). Color was developed by incubation in freshly prepared substrate solution containing 50 mM Tris-HCl, pH 7.6, 9 3,3'-diaminobenzidine-HCl (0.05 mg/ml), and 0.01% hydrogen peroxide at room temperature for 5 min. Counterstaining with hematoxylin was performed when it was necessary to identify the morphology.
Results
Either PDGF-AA or PDGF-BB local injections induced anagen phase in murine hair follicles.
The area in close proximity to the injection sites in 3 out of 5 mice became darkened in color, indicating that HFs were in the anagen hair cycle phase (Figs.1a, 1d ), whereas the injection sites using just the vehicle solution alone (0.1% BSA-PBS) all five mice retained their normal white color, suggesting that they remained in telogen phase (Fig.1g) .
Histologically, a large number of HFs in the anagen phase were observed in both the PDGF-AA or PDGF-BB injected sites. Quantitatively, PDGF-AA or PDGF-BB injected mice showed significant increases in skin thickness at the injected sites (Figs.1b, 1e) . The student's T-test demonstrated highly significant differences in skin thickness between controls and PDGF injected groups (p<0.05) (Fig.4) . Using alkaline phosphatase staining, we confirmed that HFs of PDGF injected mice were in anagen phase (Figs.1c, 1f ). There was no significant increase in skin thickness in the vehicle solution alone injection sites (Fig.1h) . Using alkaline phosphatase staining, we confirmed that mice were in telogen phase (Fig.1i). 
Anti-PDGF antibody injections interfered with the anagen induction effect of PDGFs.
In the present experiment, anti-PDGF-AA antibody was injected several minutes after the PDGF-AA injection and similarly anti-PDGF-BB antibody was injected after the PDGF-BB injection. Areas in close proximity to the injection site of all mice remained white in color, indicating that the HFs were in the telogen phase (Figs.2a, 2d) . There was no significant increase in skin thickness in the injection sites (Figs. 4, 2b,   2e ). By alkaline phosphatase staining, we confirmed that HFs in each mouse remained in telogen (Figs.2c, 2f) . These findings clearly indicated that effects of injected PDGF-AA or PDGF-BB were inhibited by the respective injections of anti-PDGF-AA antibody or anti-PDGF-BB antibodies.
Similar induction effect of anagen phase was obtained by a single injection of PDGF in hyaluronic acid.
The area in close proximity to the PDGF-AA single injection site in 3 out of 5 mice, or to the PDGF-BB single injection site in 4 out of 5 mice turned dark in color, suggesting that the HFs at the injection sites had progressed into the anagen phase (Figs.3a, 3d ). PDGF-AA or PDGF-BB single injection mice had significant increases in hair follicle tissue in the dermis. Histological analysis highlighted a significant increase in skin thickness (p<0.05) (Figs. 4, 3b, 3e) . Using alkaline phosphatase staining, we confirmed HFs in each mouse at the injection sites were in the anagen phase (Figs.3c, 3f) . Whereas the injection sites using just the vehicle solution alone (1% hyaluronic acid) all five mice retained their normal white color, no significant increases in hair follicle tissue in the dermis, from the result of alkaline phosphatase staining, suggesting that they remained in telogen phase (Figs.3g, 3h, 3i) .
Local injections of anti-PDGF-AA antibody or anti-PDGF-BB
antibody induced catagen phase.
The tissue in close proximity to the anti-PDGF-AA or anti-PDGF-BB injection sites in all mice remained bright in color, indicating that the HFs were in telogen (Figs.5a, 5d) , although the injection sites of the vehicle solution alone (0.1% BSA-PBS) in all five mice were dark in color, suggesting that they were still in anagen phase (Fig.5g) . Anti-PDGF-AA or anti-PDGF-BB injected mice showed significant decreases in hair follicle tissue in the dermis around the injection sites. Histological analysis demonstrated a significant decrease in skin thickness at the injection sites, compared with control group (p<0.05) (Figs. 6, 5b , 5e, 5h).
Using alkaline phosphatase staining, HFs at the injection sites of each mouse was confirmed to be in telogen phase (Figs.5c, 5f ). These findings show that local injections of both anti-PDGF-AA antibody and anti-PDGF-BB antibody induced catagen phase.
Expression of the HF differentiation-related signaling molecules,
Shh, Wnt5a and Lef-1, was upregulated in skin samples in which anagen had been induced by PDGF local injections.
Immunohistological observation of the anti-Shh antibody revealed that
Shh expression was seen in the dermal papilla, hair matrix, inner root sheath and outer root sheath of the hair follicles in the anagen phase 10 days after the PDGF injections (Figs. 7b,c) . Conversely, in skin tissue obtained from the mice before injection, only weak Shh expression was seen restricted in the secondary hair germ, sebaceous gland and outer root sheath of hair follicles in the telogen phase (Fig. 7a) . Real time-RT-PCR 12 using extracted mRNA from the anagen phase HF inducted by local injection of PDGF (day10) showed the upregulated expression of Shh.
The student's T-test demonstrated significant differences in Shh mRNA levels between control (before injection, day 0) and the mice skin after 10 days both PDGF-AA and PDGF-BB local injection (p<0.05) (Figs.7d, e) .
Real time-RT-PCR using extracted mRNA from skin samples after anagen induction by local injection PDGF (day 10) also showed upregulated expression of Wnt5a and Lef-1. The student's T-test demonstrated significant differences in Wnt5a and Lef-1 mRNA level between control (before injection, day 0) and the mice skin after 10 days both PDGF-AA and PDGF-BB local injection (p<0.05) (Fig. 8 ).
Stat3 immunostaining in the dermal papilla, hair matrix and inner root sheath was present in mice 10 days after the injection (Figs. 9b, c) . Before the injection, only the secondary hair germ, sebaceous gland and inner root sheath showed Stat3 expression (Fig. 9a) . There was no significant difference in Stat3 mRNA levels between control samples (day 0) and the mouse skin after 10 days of either local injection with PDGF-AA or PDGF-BB (Figs. 9d, e) .
Discussion
PDGF-AA and its receptor PDGFR-alpha are expressed in human HFs and the HF associated mesenchyme, respectively, during human fetal hair follicle morphogenesis [2] . It has previously been reported that injection of anti-PDGFR-alpha antibodies into newborn mice perturbed hair formation [3] . It had also been reported that both types of PDGF receptors 13 are expressed in human follicular keratinocytes, whereas the mesenchymal dermal papilla cells only express PDGFR-alpha and that these PDGF expression levels isoforms can be influenced in vitro by treatment with positive and negative regulator cytokines affecting hair follicle activity [4] . PDGF-A null mice develop a specific skin and hair phenotype characterized by a progressive loss of dermal mesenchyme, and impaired formation of the dermal components of HF [5] . These facts suggested a role for PDGF-AA in HF development. We think PDGFs bind to PDGF receptors on follicular keratinocytes and dermal papilla cells and induce anagen phase via Shh, Lef-1 and Wnt pathways [5] .
In this study, we analyzed the effect of cutaneous injections of recombinant human PDGF-AA and PDGF-BB on HF growth in mice. We showed that both PDGF-AA and PDGF-BB local injections resulted in induction of anagen phase in mice HFs (Fig.1) . We also demonstrated that anti-PDGF antibody injections following PDGF injections interfered with the anagen induction effect of PDGFs (Fig.2) . Furthermore, we showed that local injections of both anti-PDGF-AA antibody and anti-PDGF-BB antibody induced catagen hair cycle phase (Fig.5) . These results indicated that both PDGF-AA and PDGF-BB play a role in the induction and maintenance of the anagen hair cycle phase in mice.
Our present data are comprised first report that has analyzed the effect of cutaneous injections of recombinant human PDGF-AA and PDGF-BB on HF growth using adult mice in the telogen hair cycle stage. In the present study, we have clearly demonstrated the effects of induction of anagen phase and maintenance of murine HFs by PDGF-AA and PDGF-BB. 14 Local injection of hepatocyte growth factor was reported to result in a delayed transition from anagen to telogen but only weak anagen induction activity [8] . Subcutaneous application of slow release gelatin hydrogel beads containing basic fibroblast growth factor or hepatocyte growth factor, and collagen hydrogel containing vascular endothelial growth factor led to the appearance of dark areas on the reverse (dermal) subcutaneous side of skin tissue and increased hair shaft elongation in mice [9] . From these findings, the effects of PDGF-AA and PDGF-BB local injection appeared to be strong both in the induction and maintenance of anagen phase, although it is difficult to compare these results with ours because the two detailed experimental designs were different.
To determine the optimal treatment method, we tried two different injection methods. One involved the administration of a solution of PDGF on 5 consecutive days and the other is single injection administration using 1 % hyaluronic acid as a slow-release vehicle. We obtained similar anagen phase induction effects using both methods (Fig.1, 3) . Due to the in vivo instability and short half-life of PDGF, if administered in solution form into skin, the expected biological effects may not always be obtained or effect may be short-lived. It has been suggested that hyaluronic acid has a slow-release effect if injected with PDGF [10] . PDGF formulated with hyaluronic acid as a vehicle is thought to be a potentially useful treatment for alopecia.
Previous experimental data suggest that HF transition from telogen to anagen is associated with the activation of the Shh [11] , Wnt [12] / 15 beta-catenin [13] / Lef-1 [13] and STAT3 [14] signaling pathways. Thus, we studied the expression of Shh, Wnt5a, Lef-1 and Stat3 in the anagen PDGF induced skin samples using immunohistochemical staining and real time-reverse transcriptase-(RT)-PCR. Our results showed that expression of Shh, Wnt5a and Lef-1 was upregulated in the skin samples in which anagen had been induced by PDGF local injections (Fig.7, 8) . It was suggested that PDGF isoforms induce anagen phase via upregulation of Shh, Wnt5a and Lef-1 in mice HFs. Conversely, there were no significant differences in the Stat3 mRNA levels between control and the mice skin 10 days after both PDGF-AA and PDGF-BB treatment (Fig.9) . The reason why no significant differences were detected may be due to the fact that STAT3 might also expressed in the telogen phase.
In conclusion, PDGF isoforms have been shown both induce and maintain mouse HFs anagen phase and we demonstrated that application of PDGF-AA or PDGF-BB had a significant anagen induction effect. Local application of PDGF-AA, PDGF-BB, or a cocktail of several growth factors including PDGFs might be used as an easy and effective treatment for alopecia which is caused by an early catagen phase induction and elongation of the telogen phase of the human hair cycle. Further studies will be needed to confirm the effects of PDGFs in human hair follicles. Outer root sheaths of hair follicles in the negative control (i) specimens were negative for alkaline-phosphatase staining (arrowhead). Scale bars, 50 micro m. The T-test provided highly significant differences in skin thickness between control groups and PDGF injected groups (*p<0.05, ** p<0.005). The T-test provided significant differences in skin thickness between controls and PDGF injected groups (*p<0.05) in 28-day-old male C3H mice at the second anagen phase. 
